Quantcast

Latest Biosimilar Stories

2014-02-05 20:23:53

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/9lglrg/biologics_and) has announced the addition of the "Biologics and Biosimilars World Markets" [http://www.researchandmarkets.com/research/9lglrg/biologics_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics...

2014-02-05 16:26:30

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/37b52b/bioseparation) has announced the addition of the "Concise Analysis of the Bioseparation Systems for Global Biopharmaceutical Markets" [http://www.researchandmarkets.com/research/37b52b/bioseparation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) 'Concise Analysis of the Bioseparation Systems for Global...

2014-02-05 08:28:38

WELLESLEY, Massachusetts, February 5, 2014 /PRNewswire/ -- According to a new technical market research report, Global Markets for Generic Drugs [http://www.bccresearch.com/market-research/pharmaceuticals/generic-drugs-markets-phm009g.html ] , from BCC Research (http://www.bccresearch.com), the global generic drugs market was valued at nearly $270 billion in 2012 and is estimated at nearly $301 billion for 2013. BCC Research projects the market to grow to $518.5 billion by...

2014-02-04 08:34:03

WASHINGTON, Feb. 4, 2014 /PRNewswire-USNewswire/ -- In advance of today's Federal Trade Commission (FTC) meeting, "Follow-On Biologics Workshop: Impact of Recent Legislative and Regulatory Naming Proposals on Competition," health advocacy organizations from across the country jointly submitted a letter to FTC Commissioner Edith Ramirez, urging the Commission to give patient safety and consumer protection the important weight and priority they deserve. The Alliance for Patient...

2014-02-03 12:27:27

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Biologics and Biosimilars World Markets Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating conditions such as cancer and autoimmunity. Also known as follow-on biologics or subsequent entry biologics (SEBs), biosimilars are to biologics...

2014-02-03 00:21:09

Availability of 150 mg formulation increases dosing convenience and flexibility MUMBAI and PITTSBURGH, Feb. 3, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India. The product, which will be marketed by Mylan under the brand name Hertraz(TM), is a biosimilar to Roche's...

2014-01-31 23:24:50

The Biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. (PRWEB) January 31, 2014 The “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018”, provides a detailed overview of the major...

2014-01-31 23:00:49

The report includes perspectives from CBPartners’ senior leadership team and the firm’s Global Health Advisory Board. New York City, New York (PRWEB) January 31, 2014 CBPartners, a global leader in pricing, market access, health economics / value demonstration, and commercial planning, released its annual Year-in-Review report for 2013. The report also includes prospective viewpoints on how each major trend from the past year will likely evolve during the next year. The...

2014-01-31 08:24:53

- Realigns Existing Executive Team Expertise - DUBLIN, Jan. 31, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced a realignment of its global strategic business structure to maximize the Company's newly strengthened position as a leading specialty pharmaceutical developer, manufacturer and marketer, and to enhance Actavis' position for continued long-term growth. Under the new organizational structure, announced at Actavis' 2014 Investor Meeting in New York, Actavis' global...

2014-01-29 08:29:01

The market is expected to soar from $1.2 billion of 2013 to $24 billion in 2019 LONDON, Jan. 29, 2014 /PRNewswire/ -- The imminent entry of several companies, including big pharma, small biotech and generic participants, into the global biosimilars space will propel the market towards exponential growth. Already, Indian groups such as Dr. Reddy's Laboratories, Biocon and Reliance Life Sciences are making a concerted effort to enter the European market. Although these companies have...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.